Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Sabra Health Care REIT (SBRA)

Sabra Health Care REIT names Darrin Smith Chief Investment Officer effective January 1, 2026

Neutral Impact 3 of 5 leadership Written later

Sabra Health Care REIT appointed Darrin Smith, previously its Executive Vice President, Investments, as Chief Investment Officer, Secretary and Executive Vice President, succeeding Talya Nevo-Hacohen, who retired December 31, 2025. Michael Costa was also named Treasurer in addition to his role as Chief Financial Officer. The filing describes a routine executive transition with no financial results reported.

Key points

  • Darrin Smith appointed Chief Investment Officer, Secretary and Executive Vice President, effective January 1, 2026
  • Smith's employment agreement sets an initial annual base salary of $470,000 with a three-year initial term
  • Severance equals 1.5 times base salary plus average three-year bonus, rising to 2 times if termination occurs within two years of a change in control
  • Talya Nevo-Hacohen retired December 31, 2025 and will remain in a consulting role

The filing

CompanySabra Health Care REIT (SBRA)
Form8-K, current report
Filed with the SECJan 5, 2026, 9:15 AM ET
Accession number0001492298-26-000002

Items reported: 5.02 Director / Officer Change7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:05 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on January 05, 2026.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.